BiPar Sciences Raises $20 Million
BiPar Sciences Inc., a Brisbane, Calif.-based developer of PARP inhibitors as cancer therapies, has raised $20 million in new venture capital and debt funding. Return equity backers included Domain Associates, Canaan Partners, Vulcan Capital, PolyTechnos Venture-Partners, Asset Management Company and Quantum Technology Partners. Lighthouse Capital Partners provided the debt. No breakout was provided.
13 January 2009•3 mins read
